Literature DB >> 28961840

Acute liver graft rejection after ipilimumab therapy.

S Dueland1, T K Guren2, K M Boberg3, H M Reims4, K Grzyb4, S Aamdal2, L Julsrud5, P D Line6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28961840     DOI： 10.1093/annonc/mdx281

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

Review 1.  Liver graft rejection following immune checkpoint inhibitors treatment: a review.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Med Oncol       Date:  2019-10-11       Impact factor: 3.064

2.  Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.

Authors:  Chimaobi M Anugwom; Thomas M Leventhal; Jose D Debes
Journal:  Hepatoma Res       Date:  2022-02-11

Review 3.  An analysis report on the application of immune checkpoint inhibitors after liver transplantation.

Authors:  Man Xie; Zhi-Ping Dang; Xue-Guo Sun; Bei Zhang; Qun Zhang; Qiu-Ju Tian; Jin-Zhen Cai; Wei Rao
Journal:  Ther Adv Chronic Dis       Date:  2022-05-19       Impact factor: 4.970

4.  Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic Review.

Authors:  Kang Miao; Li Zhang
Journal:  Interdiscip Sci       Date:  2021-06-21       Impact factor: 2.233

5.  The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Authors:  Vivek Kumar; Atul B Shinagare; Helmut G Rennke; Sandeep Ghai; Jochen H Lorch; Patrick A Ott; Osama E Rahma
Journal:  Oncologist       Date:  2020-02-11

6.  Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation.

Authors:  Jikai Cui; Jizhang Yu; Heng Xu; Yanqiang Zou; Hao Zhang; Shanshan Chen; Sheng Le; Jing Zhao; Lang Jiang; Jiahong Xia; Jie Wu
Journal:  Theranostics       Date:  2020-07-01       Impact factor: 11.556

7.  Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.

Authors:  Thomas T DeLeon; Marcela A Salomao; Bashar A Aqel; Mohamad B Sonbol; Raquel T Yokoda; Ahmad H Ali; Adyr A Moss; Amit K Mathur; David M Chascsa; Jorge Rakela; Alan H Bryce; Mitesh J Borad
Journal:  J Gastrointest Oncol       Date:  2018-12

8.  Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Authors:  Dimitri Gassmann; Stefan Weiler; Joachim C Mertens; Cäcilia S Reiner; Bart Vrugt; Mirjam Nägeli; Joanna Mangana; Beat Müllhaupt; Fabienne Jenni; Benjamin Misselwitz
Journal:  Transplant Direct       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.